Jake Simson
Partner at RA Capital Management
Cambridge, Massachusetts
Overview
Work Experience
Partner
2020 - Current
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Principal
2017 - 2020
Analyst
2015 - 2017
Associate
2013 - 2015
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
PhD Candidate
2008 - 2013
- Developed and optimized a novel biological adhesive hydrogel for meniscal and cartilage tissue repair - Evaluated the potential of biologic hydrogels to regenerate bone and cartilage in a pre-clinical large animal model as a critical step to seeking funding for clinical translation - Collaborated with clinicians to develop endoscopic delivery protocol of a tissue adhesive to prevent scarring in gastroenterological and otolaryngological applications - Mentored seven undergraduate or visiting students in biomaterial development and regenerative medicine techniques
Collaborating Researcher
2010 - 2010
Developed a fully biologic hydrogel carrier to deliver and localize recombinant human bone morphogenetic protein-2 to enhance musculoskeletal tissue repair
Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.
Raised $32,000,000,000.00 from Starboard Value.
Visiting Research Associate
2009 - 2009
Provided technical support for data collection and analysis leading to approval of ChondroCelect®, the first cell therapy approved by the European Medicines Agency
Undergraduate Research Associate
2006 - 2008
- Identified and analyzed the distribution of lubricin in samples of human intervertebral disc using immunohistochemistry techniques to determine the source and role of this protein in disc function - Synthesized and characterized collagen-GAG hybrid scaffolds for use in nucleus pulposus regeneration using human mesenchymal stem cells
Education
PhD
2008 - 2013